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Abstract Tumor growth and metastasis in nasopharyngeal
carcinoma (NPC) patients was suspected as a role of sev-
eral molecular biomarkers that have been identified in
tumor specimens of patients with NPC. Invasion and
metastasis process was a complex mechanism which
involved some proteolytic enzymes, such as matrix met-
alloproteinase-9 (MMP-9). To analyze the association of
MMP-9 expression of NPC patients with cervical lymph
node metastasis. The study was conducted in oncology unit
of ORL-HNS at Dr. Soetomo General Hospital Surabaya
from May to July 2015. Formalin-fixed paraffin-embedded
biopsy specimens from NPC patients with WHO type II
and III of histopathology and clinically were divided into
four state of cervical enlargement (N0. N1. N2 and N3).
The expression of MMP-9 was obtained with immunohis-
tochemistry using rabbit polyclonal antibody Anti-MMP9
ab7299 from abcam. Cambridge-UK. Thirty-two NPC
patients were enrolled in this study. The study found a
negative expression of MMP-9 in 3.12% of samples.
Spearman rho test result was p = 0.001 with correlation
coefficient of 0.754. Spearman test resulted p value of
0.001 with a correlation coefficient of 0.754. Correlation of
matrix metalloproteinase-9 expression with cervical lymph
node metastasis (N0, N1, N2, and N3) in patients with NPC
showed a significant result (p\ 0.05). There was a strong
positive correlation between MMP-9 expressions with
cervical lymph node status in NPC patients.
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Introduction
Nasopharyngeal carcinoma (NPC) is a malignant disease in
the head-neck that many encountered in Indonesia and also
the countries in Southeast Asia with the highest incidence
rate in southern China [1]. Nasopharyngeal carcinoma has
a potential for proliferation. Invasion and metastasis are
higher than other head and neck cancers. NPC progression
has been determined based on clinical staging assessments,
i.e., the primary tumor (T), cervical lymph node metastasis
(N) and distant metastasis (M). Many NPC patients with
similar clinical stages provide different therapeutic
responses and prognoses. This suggests that TNM assess-
ments cannot yet be used to predict the progressiveness or
response to therapy (prognosis) in NPC patients.
Therefore, it is necessary to develop molecular
biomarkers on NPCs that can assist clinicians in predicting
the progression and prognosis of NPC patients. About 90%
of NPC patients are encountered cervical lymph node
enlargement [2]. The biological properties of NPC are
determined by cervical lymph node status. Patients with
large cervical lymph node enlargement have a tendency of
poor prognosis. This indicates the NPC’s progressivity is
determined by the status of cervical lymph node [3].
Matrix metalloproteinase-9 was reported to degrade the
extracellular matrix and basal membrane with the main
component of type IV collagen as a result of triggering
angiogenesis and resulting in increased tumor growth
(proliferation), invasion and metastasis both lymphogenic
and hematogenous [4].
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Several researchers reported the association of MMP-9
expression with growth and metastasis in NPC through
immunohistochemical examination of NPC tissue [2, 4–6].
The research in 28 patients with NPC had a significant
increased of MMP-9 expression in NPC group with
advanced metastasis compared to NPC group of initial
metastasis and NPC without metastasis (p\ 0.05) [5].
Nasopharyngeal carcinoma is a neoplasm derived from
the nasopharynx epithelial mucosa and is suspected to be
closely related to VEB infection, diet and genetic factors
[4]. Latent membrane protein-1 is suggested to have a role
in the pathogenesis of NPC. Latent membrane protein-1 is
required for B lymphocyte transformation, meanwhile,
LMP-1 expression is found in 70% NPC and in all pre-
invasive lesions of VEB [2].
Latent membrane protein-1 from VEB plays a role in
MMP-9 synthesis in the nucleus through activation of
Extracellular signal regulating kinase-Mitogen-Activated
Protein Kinases (ERK-MAPK) that activates protein-1
activator (AP-1). Latent membrane protein-1 also plays a
role in the regulation of MMP-9 expression through the
nuclear factor-jB (NF-jB) transcription factor.
Matrix metalloproteinase-9 is a gelatinase produced and
secreted by various cancer cells, stromal cells, fibroblasts,
and inflammatory cells. This enzyme is secreted and
retained as an inactive zymogen (pro MMP) in the cyto-
plasm of cancer cells. Then, they are activated in the
extracellular space. Matrix metalloproteinase-9 has the
ability to degrade the components of MES and basal
membranes. On the other hand, MMP-9 also stimulates
growth factors thus the process of tumor invasion becomes
easier. Matrix metalloproteinase-9 triggers an angiogenesis
process that will increase tumor growth (proliferation),
invasion, and metastasis with clinical manifestations of
primary tumor enlargement in the nasopharynx and cervi-
cal lymph node (status) extension. MMP-9 activity can be
inhibited by endogenous inhibitors of tissue inhibitor of
metalloproteinase (TIMP) and synthetic inhibitors such as
bathymastat, ilomastat, and marimastat [7].
Methods
This research was an analytic observational with cross-
sectional approach from May to July 2015 in Oncology
Unit, Installation of Anatomical Pathology at Dr. Soetomo
General Hospital Surabaya, and Laboratory of Anatomical
Pathology at Dr. Sardjito Yogyakarta, Indonesia.
The sample used in this study was NPC patients, either
without cervical lymph node enlargement (N0) or with
cervical lymph node enlargement (N1 N2 N3), nasopha-
ryngeal biopsy of a WHO type II and III carcinoma, and
never received definitive treatment (radiotherapy,
chemotherapy or a combination of both). Sampling tech-
nique used was consecutive sampling.
The inclusion criteria were; NPC patients who have
sufficient paraffin blocks of nasopharyngeal biopsy to
conduct an immuno-histochemistry examination and
MMP-9 expression assessment, and patients willing to
participate in the informed consent. The exclusion criteria
were; the preparation of paraffin block was damaged or not
eligible thus the immunohistochemical examination cannot
be performed to assess MMP-9 expression.
Immunohistochemical examination to determine MMP-
9 expression was using rabbit polyclonal antibody Anti-
MMP9 ab7299 (abcam Cambridge-UK). Furthermore, the
reading and assessment of MMP-9 expression were con-
ducted by PA specialist doctor (consultant) in PA Labo-
ratory of Dr. Sardjito Hospital Yogyakarta. The researchers
performed a neck examination to assess the status of the
cervical lymph node. If nodules/lymph node enlargement
in the neck was found, then, the measurement was per-
formed using vernier callipers of AMC-WP017 (in
centimetre).
Data obtained in this study were analyzed by Spear-
man’s rho test to determine the relationship between MMP-
9 expressions with cervical lymph node status (N0 N1, N2,
N3) in NPC patients. The level of significance was
(a) = 0.05. The research protocol was approved by the
ethic committes of Dr. Soetomo Teaching Hospital Sur-
abaya Indonesia.
Results
We obtained that the most age group was 50–59 years of
14 patients (43.75%), meanwhile, 20–29 years age group
found one patient (3.12%). The youngest was 22 years old
and the oldest was 68 years old. The result of data analysis
based on sex obtained 20 males (62.50%) and 12 females
(37.50%). Comparison of men and women was 1.6:1. The
most common occupation in this study was farmer of 14
patients (43.75%) and eight patients (25.00%) did not work
(housewives). Based on data analysis, the most
histopathology type was WHO type III of 28 patients
(87.50%) then followed by WHO type II of 4 patients
(12.50%). WHO type I was excluded because the MMP-9
expression occurred due to its association with VEB.
Association of MMP-9 Expression with Cervical
Lymph Node Status in NPC Patients
We found an increase in the number of cells that provided
MMP-9 expressions of weak, medium, strong and very
strong on the status of cervical lymph node (N0, N1, N2,
and N3). There was a negative MMP-9 expression of
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3.12%, weak positive MMP-9 expression of 21.87%, and a
very strong positive MMP-9 expression of 34.37%. N0
group obtained a negative MMP-9 expression in one
sample.
Groups N1, N2, and N3 did not obtain negative MMP-9
expression. The result of MMP-9 expression was weak
positive by 21.87% of all samples. Group N0 obtained a
weak positive MMP-9 expression in three samples. Groups
of N1 and N2 obtained two samples in each group and no
positive MMP-9 expression was found in N3. Moderate
positive MMP-9 expression was found in 25.00% of all
samples. Group N1 obtained moderate positive expression
in three sample and group of N2 found in five samples.
There was no positive MMP-9 expression in the N0 and N3
groups. Positive MMP-9 expression was found in 15.62%
of all samples. Group N2 obtained a strong positive
expression in three samples and group of N3 found two
samples. Positive MMP-9 expression was not found in the
group of N0 and N1. The result of positive MMP-9
expression was very strong at 34.37% of all samples.
Group N2 obtained a very strong expression in five samples
and group of N3 found six samples. Positive MMP-9
expression was not found in the N0 and N1 groups.
Spearman’s rho test of MMP-9 expression with cervical
lymph node status (N0 N1, N2, N3) in NPC patients
obtained p = 0.001 and correlation coefficient (r) 0.754. It
means that there was a significant relationship (p\ 0.05)
of MMP-9 expression with cervical lymph node status.
Correlation strength of 0.754 means a stronger MMP-9
expression, the higher the status of a cervical lymph node
in patients with NPC. There was a positive correlation
between MMP-9 expression with cervical lymph node
status (N0 N1, N2 and N3) in NPC patients.
Immunohistochemical results of MMP-9 in NPC tissue
were identified by the presence of dark brown color in the
cell nucleus and cytoplasm of tumor cells. The observation
and analysis of MMP-9 expression were performed by a
binocular microscope with 400 9 magnification.
Immunohistochemical staining results were shown in
Figs. 1, 2, 3, 4 and 5.
Discussion
The most common NPC patients in the 40–49 years group
of 35.8% followed by the 30–39 years group of 21.4% [8].
Nasopharyngeal carcinoma can be found at all ages.
Although some researchers reported a number of cases of
NPC in children, however, it was rare to found at age under
20 years [1]. The distribution of NPC patients based on the
age of incidence increased at age of 45–54 years then it
decreased. Most NPC patients were found at the productive
age of 30–59 years (about 80%) then peaked at the age of
40–49 years. The highest incidence was at the age of
40–60 years. The workers at the productive age were often
going out of the house thus the possibility of exposure to
carcinogenic substances or pollution was higher [1, 9].
Cancer cells emerged from normal cells who undergone
a malignant transformation as a result of spontaneous
mutations or carcinogen induction. The presence of contact
with carcinogens until the onset of cancer cells took a long
induction time up to 15–30 years [10]. VEB infection as a
risk factor NPC has a latent period in the infected
nasopharyngeal cells about 20–25 years without symptoms
of primary VEB infection in childhood and asymptomatic.
The process of malignancy in NPC occurred after latent
infection. This might have caused a high incidence to be
found at the age of 40–60 years [11].
Fig. 1 MMP-9 staining results on KNF tissue with Immunohisto-
chemical techniques. There was no apparent brown color in the cell
nucleus and cytoplasm; showed a negative MMP-9 (-) expression
Fig. 2 MMP-9 staining results in KNF tissue with Immunohisto-
chemical techniques. Dark brown color in the cell nucleus and
cytoplasm (yellow arrow) appears. The colored cell B 25%, indicates
a weak positive MMP-9 (?) expression
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The high incidence in male patients compared to female
was reported in almost all studies. It was suspected to be
related to habits and occupations that cause men to be
exposed more frequently to carcinogens of NPCs. Expo-
sure to steam, smoke dust, and chemical gas at work
increased the risk of NPC by 2–6 times. Meanwhile, the
exposure to formaldehyde in the workplace increased the
risk of NPC by 2–4 times. Increased risk also occurred in
workers who inhale firewood smoke and the risk increased
by 2 times in workers who exposed to industrial heat and
combustion products [12].
There was a difference in the distribution of ethnic
groups due to the largest population of the population in the
city of Surabaya as the location of research was the Java-
nese. Based on immunogenic studies in Jakarta (1997)
reported that 20 NPC patients (15 males and 5 females)
obtained HLA-A24 (RR: 5.43) and HLA-B63 (RR: 5.96).
These two class I antigen phenotypes was suspected to be
the cause of NPC for indigenous Indonesians [1].
Based on the literature, carcinogenic associated with
NPC incidences were dust or particles of moderate size
(5–10 lm). It was due to particles of that size was easily
absorbed by the nasopharyngeal mucosa. Several epi-
demiological studies have shown increased NPC risk fac-
tors in workers that exposed to wood dust with specific
time periods and doses. Other studies have also found an
increased risk of NPCs incidences in people who work in
environments with pollution from burning (charcoal). The
ratio of exposure to workers cannot be determined pre-
cisely because it is determined by frequencies and areas
that are endemic [13].
Particles in smoke derived from burning coal, wood and
other materials were mostly stored in the nasopharynx.
There were several major chemicals known as a cause of
NPCs based on occupational exposure, such as bleach, acid
and base, sulfuric acid, inks, formaldehyde and pesticides.
The risk of exposure for 10–20 years as a latent effect had
a significant association with NPC13 events [14].
The most common histopathology type of NPC in
Indonesia was WHO type III. Results of research in other
big cities in Indonesia also showed a different distribution
of histopathology type [15]. The Spearman’s rho test of the
association of MMP-9 expression with cervical lymph node
status (N0, N1, N2, and N3) in NPC patients showed a
result of p = 0.001 and r = 0.754. MMP-9 expression with
cervical lymph node status was found to be significant with
r = 0.754. Thus, the hypothesis of this study was evident.
We found a positive correlation between MMP-9 expres-
sion and cervical lymph node status (N0, N1, N2, and N3).
This could be interpreted as the stronger the MMP-9
expression, the higher the status of a cervical lymph node
in patients with NPC.
Fig. 3 MMP-9 results results on KNF tissue with Immunohisto-
chemical techniques. Dark brown color in the cell nucleus and
cytoplasm (yellow arrow) appears. Tinted cells[ 25– B 50% shows
a moderate positive MP-9 expression (??)
Fig. 4 MMP-9 staining results on KNF tissue with Immunohisto-
chemical techniques, dark brown color in the cell nucleus and
cytoplasm (yellow arrow) appears. Tinted cells[ 50– B 75% shows
a strong positive MMP-9 (??) expression
Fig. 5 MMP-9 staining results in KNF tissue with Immunohisto-
chemical techniques. Dark brown color appears on the cell nucleus
and cytoplasm (yellow arrow) appears. Tinted cells[ 75% shows a
very strong positive MMP-9 (????) expression
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There was a positive correlation between increased
MMP-9 expression and cervical lymph node status (N0,
N1, N2 and N3) in NPC patients. It suggested that tumor
progression could be predicted from the level of MMP-9
expression. The higher the MMP-9 expression in NPC
tumor cells, the higher the cervical lymph node status of
NPC patients. The results of this study were in accordance
with other studies that obtained a significant increased of
MMP-9 expression in patients with advanced stage NPC
(p\ 0.05) [4]. The increased of MMP-9 expression was
associated with a classification of T (large tumors), clas-
sification N (metastasis in the lymph node), and clinical of
NPC patients.
Other research in Department of Pathology Anatomy,
Faclty of Medicine, Universitas Airlangga, Dr. Soetomo
General Surabaya Surabaya on 28 patients with NPC
showed a significant increase of MMP-9 expression in the
NPC group with advanced metastasis than in the initial
NPC metastasis group and NPC without metastasis [5]. It
was concluded that there was an association between
MMP-9 expression with tumor progression or degree of
lymph node metastasis in NPC (p\ 0.05). It means that
the stronger the MMP-9 expression, the higher the degree
of metastasis in the NPC. Other studies on 146 patients
with NPC and 110 invidu as control resulted that an
increase in MMP-9 expression was associated with clinical
characters, i.e., stadium (p\ 0.001), primary tumor in the
nasopharynx (p = 0.016), metastasis in cervical lymph
node (p = 0.002), histology (p = 0.002) and poor overall
survival (p = 0.049) [6]. Other studies suggested that
MMP-9 expression was not correlated to histology, gender,
age, T classification or staging classification, however, it
related to metastasis in cervical lymph node (p = 0.004)
[2].
Matrix metalloproteinase-9 is a proteolytic enzyme that
plays an important role in the process of metastasis. After
tumor cells are released from each other due to E-cadherin
activity, then the invasion of tumor cells into surrounding
tissues involving catalytic enzymes is proceed. Matrix
metalloproteinase-9 plays an important role in tumor and
metastatic progression in both regional and remote [16].
Matrix metalloproteinase-9 is part of the Zn2? depen-
dent endopeptidase family, working at neutral pH, is
secreted in an inactive zymogen, and require proteolytic
activation [17]. MMP-9 expression will increase in
malignancy; furthermore, tumor cells also produce MMP-9
and play an active role in the proliferation process. Matrix
metalloproteinase-9 acts as a mediator on the activation of
growth factors, bioavailability of receptors and signaling,
adhesion and cell motility, apoptosis, survival and angio-
genesis [18].
The most important part of the metastasis process is the
degradation of the basal membrane and the extracellular
matrix. Basal membrane is an important barrier. Basal
membrane damage is a major predictor of tumor invasion.
Type IV collagen is a major component of basal membrane
components. Matrix metalloproteinase-2 and MMP-9 are
type IV collagenases that are closely related to tumor
metastasis [17]. Nasopharyngeal carcinoma is a neoplasm
derived from the nasopharynx epithelial mucosa and is
thought to be closely related to VEB infection, diet, and
genetic factors [4].
Several studies described different methods has been
used to examine Matrix metalloproteinase-9. Immunohis-
tochemical expression and western blot analysis can be use
to revealed any expression of Matric metalloproteinase-9 in
tissue. Murawski et al. [19], previous study examine Matrix
metalloproteinase-9 in breast cancer, revealed that the
standard routine histopatological analysis misclassified
almost 42% of patients as negative for axillary node
metastasis.
Conclusion
There was a strong positive association between Matrix
metalloproteinase-9 expression and cervical lymph node
status in patients with nasopharyngeal carcinoma, and
therefore immunohistochemical expression of this marker
should be considered as a useful method to predict the
progressiveness or response to therapy in nasopharyngeal
cancer patients. Additional studies including western blot
analysis could be use to confirm the Matrix metallopro-
teinase-9 expression.
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